ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,692Medicare Part D Prescriptions Filled, Including Refills

Rank: 24 out of 559

$339K Total Retail Price of All Prescriptions

Rank: 95 out of 559

502 Patients Receiving at Least One Drug in Part D
63%Patients 65 Years and Older
80% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in New Mexico
Lower avg

Schedule Two
Controlled Substances

13% of this provider’s 502 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

28% of this provider’s 502 patients filled at least one prescription for a schedule three drug, compared to an average of 10%.

Risky Drugs to Seniors

3% of this provider’s 6,553 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

16% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$32 was the average price of a prescription from this provider, compared to $53 among peers.

Prescriptions per Patient

21 is the average number of prescriptions (including refills) per patient, compared to an average of 14.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in New Mexico
HYDROCODONE-ACETAMINOPHEN 798 357 S3 1 7
LISINOPRIL 685 475 2 1
METFORMIN HCL 369 245 3 5
LEVOTHYROXINE SODIUM 339 241 4 2
OMEPRAZOLE 272 209 5 4
IBUPROFEN 247 102 6 30
RANITIDINE HCL 246 154 7 26
MELOXICAM 229 132 8 42
METOPROLOL SUCCINATE 215 152 9 16
TRAMADOL HCL 212 110 10 27
ZOLPIDEM TARTRATE 201 87 11 17
SIMVASTATIN 191 132 12 3
GLIMEPIRIDE 174 138 13 53
NAPROXEN 172 120 14 79
AMLODIPINE BESYLATE 167 122 15 6
CYCLOBENZAPRINE HCL 165 12 R 16 54
FUROSEMIDE 161 89 17 11
ALENDRONATE SODIUM 152 141 18 13
AZITHROMYCIN 146 80 19 39
NABUMETONE 141 84 20 121
OXYCODONE-ACETAMINOPHEN 140 66 S2 21 44
CLOPIDOGREL 140 110 21 51
GEMFIBROZIL 134 75 23 71
PAROXETINE HCL 128 62 24 48
AMOXICILLIN 124 61 25 106
AMITRIPTYLINE HCL 113 60 R 26 58
TRIAMCINOLONE ACETONIDE 110 87 27 84
TRIAMTERENE-HYDROCHLOROTHIAZID 98 66 28 112
PROAIR HFA 98 38 28 29
GLIPIZIDE 91 40 30 31
FLUTICASONE PROPIONATE 86 31 31 22
AMOX TR-POTASSIUM CLAVULANATE 86 42 31 98
TAMSULOSIN HCL 84 83 33 25
CLONIDINE HCL 81 48 34 68
SERTRALINE HCL 81 24 34 19
SULFAMETHOXAZOLE-TRIMETHOPRIM 81 51 34 96
METOPROLOL TARTRATE 80 64 37 12
GABAPENTIN 77 44 38 9
PLAVIX 76 62 39 76
ROPINIROLE HCL 69 37 40 95
OXYCODONE HCL-ACETAMINOPHEN 67 11 S2 41 70
LOVASTATIN 61 56 42 10
KETOCONAZOLE 60 35 43 192
CRESTOR 59 47 44 33
CIPROFLOXACIN HCL 59 37 44 60
POTASSIUM CHLORIDE 59 34 44 23
ATENOLOL 57 41 47 15
TRAZODONE HCL 55 19 48 28
WARFARIN SODIUM 55 45 48 24
MUPIROCIN 53 25 50 182
HYDROCHLOROTHIAZIDE 53 21 50 8
NEXIUM 52 40 52 57
DONEPEZIL HCL 51 51 53 36
CARVEDILOL 50 50 54 38
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Aug. 1, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.